B Bio-Rad Laboratories Inc
| Market Cap | $7.56B |
| P/E Ratio | 10.05 |
| Forward P/E | 24.70 |
| Dividend Yield | — |
| Beta | 1.16 |
| 52W Range | $216.56 - $339.75 |
| # Hedge Funds | 4 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 4 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Mason Hawkins Southeastern Asset Management | 3.07% | $68.97M | 227,630 | Reduce 4.06% |
| Charles Bobrinskoy Ariel Investments | 2.50% | $231.69M | 764,672 | Reduce 5.54% |
| Steven Romick First Pacific Advisors | 1.60% | $121.64M | 401,457 | Add 1.79% |
| First Eagle Investment Management First Eagle Investment Management | 1.37% | $778.83M | 2,570,473 | Add 1.99% |
Frequently Asked Questions
What is BIO stock price today?
Bio-Rad Laboratories Inc (BIO) is currently trading at $279.99. The stock has a 52-week range of $216.56 to $339.75 and a market capitalization of $7.56B.
Is BIO a good stock to buy in 2026?
Bio-Rad Laboratories Inc has a P/E ratio of 10.0 (forward P/E: 24.7), a dividend yield of none, and 1-year performance of +19.3%. 4 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BIO stock?
There have been 0 insider transactions for BIO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BIO stock performed over the past year?
Bio-Rad Laboratories Inc (BIO) has returned +19.3% over the past 12 months. The stock traded between $216.56 and $339.75 during this period, and is currently at $279.99.
Which hedge funds own BIO (Bio-Rad Laboratories Inc)?
4 tracked hedge funds currently hold BIO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BIO's market cap and valuation?
Bio-Rad Laboratories Inc (BIO) has a market capitalization of $7.56B. The trailing P/E ratio is 10.0 and forward P/E is 24.7. The stock is classified in the Healthcare sector.
What is BIO's revenue and profitability?
Bio-Rad Laboratories Inc reported revenue of $2.58B with net income of $759.90M and a profit margin of 0.29%. The stock has a beta of 1.16.
What sector is BIO in and who are its biggest institutional holders?
Bio-Rad Laboratories Inc (BIO) operates in the Healthcare sector. It is held by 4 tracked hedge funds. See the ownership table above for the complete list.